New analysis of GLP-1 drugs suggests people who stopped using medications regained 60% of weight lost

[ad_1] New analysis is taking a better have a look at what can occur a yr or extra after folks cease taking GLP-1 drugs.

A brand new systematic assessment printed within the journal eClinicalMedicine on Wednesday examined 48 research that analyzed and predicted the outcomes of people that both had diabetes or had been chubby or overweight and took well-liked GLP-1 drugs reminiscent of liraglutide (underneath model names reminiscent of Victoza and Saxenda), semaglutide (underneath model names reminiscent of Ozempic, Wegovy, Rybelsus) and tirzepatide (underneath model names like Mounjaro and Zepbound).

Bins of Ozempic and Mounjaro, semaglutide and tirzepatide injection medicine used for treating sort 2 diabetes and made by Novo Nordisk and Lilly at a Rock Canyon Pharmacy in Provo, Utah, March 29, 2023.

George Frey/Reuters, FILE

For individuals who stopped taking GLP-1 weight-loss drugs, sufferers regained about 60% of the burden they misplaced inside a yr, based on the assessment's evaluation. When researchers used pc statistical modeling to see what might occur after greater than a yr off of the drugs, it prompt these sufferers might regain about 75% of the burden they'd misplaced.

ABC Information chief medical correspondent Dr. Tara Narula mentioned on "Good Morning America" Thursday that the brand new evaluation underscores how weight reduction requires an "individualized strategy."

"There are some individuals who can come off of them and preserve the burden loss. There are others who will have to be on some kind of dose taper or some who want to remain on the identical dose without end," Narula mentioned.

As a result of the assessment of 48 research, though complete, checked out a large and numerous group of individuals -- from these with situations reminiscent of diabetes and kidney illness, and people with completely different beginning and finish factors and who took completely different drugs -- the conclusions drawn additionally spotlight its limitations.

Narula mentioned the excellent news is that GLP-1 drugs have been efficiently proven to assist folks lose some weight total.

"The essential issue is that some weight was not regained, and while you have a look at the loss from baseline weight, it is about 4% to five% of the baseline weight that was misplaced and maintained. And that is not clinically insignificant," Narula mentioned.

Other than GLP-1 drugs, Narula famous that different methods reminiscent of life-style counseling, common train and different drugs can even assist folks drop some pounds and hold it off over the long-term.

"We predict that a few of these folks could also be altering habits, diet, life-style, [and] additionally could also be altering the hormones of their physique by being on [GLP-1 medications], altering how their mind kind of operates or capabilities completely," Narula mentioned. "There's some knowledge to counsel {that a} dose tapering technique, so the place you reduce or decrease the doses over time would possibly stop weight regain."